Andrew John Nichols's most recent trade in Astria Therapeutics Inc was a trade of 55,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astria Therapeutics Inc | Andrew John Nichols | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Astria Therapeutics Inc | Andrew John Nichols | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 600,000 | 600,000 | - | - | Stock Option (right to buy) |